[Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases] - PubMed
- ️Mon Jan 01 1996
. 1996 Nov 16;107(17):660-3.
[Article in Spanish]
Affiliations
- PMID: 9064408
[Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases]
[Article in Spanish]
F Cobo et al. Med Clin (Barc). 1996.
Abstract
The chronic myeloproliferative disorders (CMPD) are considered the main etiology of Budd-Chiari syndrome in Western countries. Moreover, an occult CMPD has been recently identified in most patients with idiopathic hepatic vein thrombosis. In order to determine the frequency of the association between the above entities and to analyze the clinical and hematologic features of such patients, fourteen cases of Budd-Chiari syndrome diagnosed at a single institution over a five year period were reviewed. In 6 patients a CMPD was identified, with this being the first cause of the syndrome. Median age of the later six patients was 32 years (range: 14-54), and 4 were females. In all cases the CMPD was suspected due to the presence of hematological abnormalities, including a high hematocrit (5 cases), leucocytosis (4 cases) and thrombocytosis (3 cases). Five patients had polycythemia vera (PV) and one idiopathic myelofibrosis. In an additional Budd-Chiari patient with polycythemia, PV was ruled out on the basis of high serum erythropoietin and the absence of endogenous growth of erythroid colonies in the hematopoietic progenitor culture. The CMPD treatment included phlebotomies and hydroxiurea, whereas the Budd-Chiari syndrome was treated in most patients with transjugular intrahepatic portosystemic stent-shunt. One patient died from a gastrointestinal hemorrhage at 48 months from Budd-Chiari diagnosis, and the remaining five are alive after a median follow-up of 28 months.
Similar articles
-
De Stefano V, Teofili L, Leone G, Michiels JJ. De Stefano V, et al. Semin Thromb Hemost. 1997;23(5):411-8. doi: 10.1055/s-2007-996117. Semin Thromb Hemost. 1997. PMID: 9387199 Review.
-
Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
Panagiotou I, Kelekis DA, Karatza C, Nikolaou V, Mouyia V, Brountzos EN. Panagiotou I, et al. Hepatogastroenterology. 2007 Sep;54(78):1813-6. Hepatogastroenterology. 2007. PMID: 18019724
-
Walter E, Muntwyler J, Bertschinger P, Flury R, Ochs A, Haag K, Rössle M, Blum HE. Walter E, et al. Schweiz Med Wochenschr. 1993 Sep 11;123(36):1696-702. Schweiz Med Wochenschr. 1993. PMID: 8211021 German.
-
Brière JB. Brière JB. Semin Thromb Hemost. 2006 Apr;32(3):208-18. doi: 10.1055/s-2006-939432. Semin Thromb Hemost. 2006. PMID: 16673275 Review.
-
[Budd-Chiari syndrome--from diagnosis to treatment--case reports].
Kozielewicz D, Smukalska E, Dybowska D. Kozielewicz D, et al. Pol Merkur Lekarski. 2008 Mar;24(141):260-4. Pol Merkur Lekarski. 2008. PMID: 18634297 Polish.
Cited by
-
Cardiovascular Manifestations of Myeloproliferative Disorders: A Review of the Literature.
Saif MW, Khan U, Greenberg BR. Saif MW, et al. Hosp Physician. 1999 Jul;35(7):43-54. Hosp Physician. 1999. PMID: 35450273 Free PMC article. No abstract available.
-
Cario H, Schwarz K, Herter JM, Komrska V, McMullin MF, Minkov M, Niemeyer C, Pospisilova D, Reinhard H, Debatin KM, Pahl HL. Cario H, et al. Br J Haematol. 2008 Aug;142(4):622-6. doi: 10.1111/j.1365-2141.2008.07220.x. Epub 2008 Jun 28. Br J Haematol. 2008. PMID: 18557746 Free PMC article.
-
Clinical and hematological presentation of children and adolescents with polycythemia vera.
Cario H, McMullin MF, Pahl HL. Cario H, et al. Ann Hematol. 2009 Aug;88(8):713-9. doi: 10.1007/s00277-009-0758-y. Epub 2009 May 26. Ann Hematol. 2009. PMID: 19468728 Free PMC article. Review.